159 related articles for article (PubMed ID: 8050825)
1. Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells.
Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
Int J Cancer; 1994 Aug; 58(3):440-5. PubMed ID: 8050825
[TBL] [Abstract][Full Text] [Related]
2. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
3. Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines.
Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
Eur J Cancer; 1994; 30A(5):678-82. PubMed ID: 8080687
[TBL] [Abstract][Full Text] [Related]
4. Effects of TGF beta1 autocrine blockage on osteosarcoma cells.
Liu Y; Zheng QX; Du JY; Yang SH; Shao ZW; Xiao BJ
Chin Med Sci J; 2004 Jun; 19(2):155-6. PubMed ID: 15250258
[TBL] [Abstract][Full Text] [Related]
5. Construction of antisense transforming growth factor beta 1 gene and its effect on the proliferation by expression in osteosarcoma cells.
Liu Y; Zheng Q; Du J; Yang S; Shao Z; Xiao B
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):163-5. PubMed ID: 12973938
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
7. Relation between histological intensity of transforming growth factor-beta isoforms in human osteosarcoma and the rate of lung metastasis.
Yang RS; Wu CT; Lin KH; Hong RL; Liu TK; Lin KS
Tohoku J Exp Med; 1998 Feb; 184(2):133-42. PubMed ID: 9605020
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of transforming growth factor-beta type I receptor by interferon consensus sequence-binding protein in osteosarcoma cells.
Sung JY; Yoon K; Ye SK; Goh SH; Park SY; Kim JH; Kang HG; Kim YN; Park BK
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):761-772. PubMed ID: 30710564
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta-induced mitogenesis of human bone cancer cells.
Datta HK; Zaidi M; Champaneri JB; MacIntyre I
Biochem Biophys Res Commun; 1989 Jun; 161(2):672-6. PubMed ID: 2735916
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression.
Kloen P; Gebhardt MC; Perez-Atayde A; Rosenberg AE; Springfield DS; Gold LI; Mankin HJ
Cancer; 1997 Dec; 80(12):2230-9. PubMed ID: 9404699
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
13. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
14. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
DeCoteau JF; Knaus PI; Yankelev H; Reis MD; Lowsky R; Lodish HF; Kadin ME
Proc Natl Acad Sci U S A; 1997 May; 94(11):5877-81. PubMed ID: 9159168
[TBL] [Abstract][Full Text] [Related]
15. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
16. Autocrine growth mechanism by transforming growth factor (TGF)-beta 1 and TGF-beta 1-receptor regulation by epidermal growth factor in a human endometrial cancer cell line IK-90.
Sakata M; Kurachi H; Ikegami H; Jikihara H; Morishige K; Miyake A; Terakawa N; Tanizawa O
Int J Cancer; 1993 Jul; 54(5):862-7. PubMed ID: 8392035
[TBL] [Abstract][Full Text] [Related]
17. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
[TBL] [Abstract][Full Text] [Related]
18. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.
Mórocz IA; Schmitter D; Lauber B; Stahel RA
Br J Cancer; 1994 Nov; 70(5):850-6. PubMed ID: 7947089
[TBL] [Abstract][Full Text] [Related]
19. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines.
Kido A; Krueger S; Haeckel C; Roessner A
Clin Exp Metastasis; 1999; 17(10):857-63. PubMed ID: 11089884
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells.
Nikitovic D; Zafiropoulos A; Katonis P; Tsatsakis A; Theocharis AD; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Jan; 58(1):47-53. PubMed ID: 16540432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
